CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.

导出 OA

翻译打印收藏纠错

作者： Malinee,Thanee ^[1] ; Watcharin,Loilome ^[2] ; Anchalee,Techasen ^[1] ; Eiji,Sugihara ^[2] ; Shogo,Okazaki ^[2] ; Shinya,Abe ^[3] ; Shiho,Ueda ^[4] ; Takashi,Masuko ^[4] ; Nisana,Namwat ^[5] ; Narong,Khuntikeo ^[6] ; Attapol,Titapun ^[5] ; Chawalit,Pairojkul ^[5] ; Hideyuki,Saya ^[1] ; Puangrat,Yongvanit ^[2]

作者单位： Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. ^[1] Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. ^[2] Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand. ^[3] Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University, Tokyo, Japan. ^[4] Cell Biology Laboratory, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Kindai University, Higashiosaka, Japan. ^[5] Laboratory of Biological Protection, Department of Biological Responses, Institute for Virus Research, Kyoto University, Kyoto, Japan. ^[6] Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. ^[7] Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. ^[8]

关键词 CD44v cholangiocarcinoma opisthorchiasis redox status sulfasalazine